When.com Web Search

  1. Ads

    related to: lipitor equivalent of zocor 40

Search results

  1. Results From The WOW.Com Content Network
  2. Ezetimibe/simvastatin - Wikipedia

    en.wikipedia.org/wiki/Ezetimibe/simvastatin

    With median follow-up of 6 years, simvastatin+ezetimibe was found to reduce the primary outcome of CV mortality, major CV event, or nonfatal stroke (34.7% vs. 32.7%; P=0.016; NNT 50 per 7 years or NNT 350 per 1 year ). There was no reduction in all-cause or CV mortality with simvastatin+ezetimibe, though there was a reduction in MI and stroke. [6]

  3. Ezetimibe/atorvastatin - Wikipedia

    en.wikipedia.org/wiki/Ezetimibe/atorvastatin

    Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug. In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet. [ 1 ]

  4. Statin - Wikipedia

    en.wikipedia.org/wiki/Statin

    Researchers tested simvastatin, later sold by Merck as Zocor, on 4,444 patients with high cholesterol and heart disease. After five years, the study concluded the patients saw a 35% reduction in their cholesterol, and their chances of dying of a heart attack were reduced by 42%. [12] [191] In 1995, Zocor and Mevacor both made Merck over US$1 ...

  5. FDA Approves Powerful New Cholesterol Drug

    www.aol.com/news/2013-05-03-fda-approves...

    Merck gained Food and Drug Administration approval for its powerful new cholesterol drug Liptruzet, a combination of two already-approved drugs, Pfizer's Lipitor and Merck's Zetia. Merck already ...

  6. Pfizer Sues Merck to Block Lipitor/Zetia Combo Pill - AOL

    www.aol.com/2011/10/13/pfizer-sues-merck-to...

    It isn't often that the two biggest of Big Pharma find themselves in a patent fight. Usually, it's a branded drugmaker fighting off a generics challenge from a copycat drugmaker. But this time it ...

  7. Atorvastatin - Wikipedia

    en.wikipedia.org/wiki/Atorvastatin

    On 9 November 2012, Indian drugmaker Ranbaxy Laboratories Ltd. voluntarily recalled 10-, 20- and 40-mg doses of its generic version of atorvastatin in the United States. [ 134 ] [ 135 ] [ 136 ] The lots of atorvastatin, packaged in bottles of 90 and 500 tablets, were recalled due to possible contamination with very small glass particles similar ...